Funding Clinical Trials
Our Agency funds clinical trials testing promising stem cell or gene therapies for currently incurable diseases or disorders to help patients with unmet medical needs. For basic information about stem cell trials, visit our Clinical Trials 101 page. For a list of clinical trials that are a result of early-stage CIRM grants click here.
96
CIRM-FUNDED CLINICAL TRIALS
| Disease Areas | Investigator | Organization | Phase | Trial Status | Target Enrollment | Detail |
|---|---|---|---|---|---|---|
| Age-related macular degeneration | Dr. Mark S Humayun | University of Southern California | Phase 1 | Unknown status | 16 | |
| Age-related macular degeneration | Dr Jane S Lebkowski | Regenerative Patch Technologies LLC | Phase 2 | Launching | N/A | |
| Bone or Cartilage Disease Hearing Loss Intellectual Disability Metabolic Disorders Vision Loss |
Dr Robert Hayes | Immusoft Corporation | Phase 1 | Launching | N/A | |
| Corneal Damage | Dr. Sophie X Deng | University of California, Los Angeles | Phase 1 | Recruiting | 20 | |
| Corneal Damage | R. Kim Brazzell | Combangio, Inc. | Phase 2 | Launching | N/A | |
| Retinitis Pigmentosa | Dr. Henry John Klassen | University of California, Irvine | Phase 1/2 | Completed | 28 | |
| Retinitis Pigmentosa | Henry John Klassen | jCyte, Inc | Phase 2 | Completed | 84 | |
| Retinitis Pigmentosa | Clive Svendsen | Cedars-Sinai Medical Center | Phase 1 | Recruiting | 16 | |
| Retinitis Pigmentosa | Henry John Klassen | jCyte, Inc | Phase 2 | Completed | 84 |